Activation and function of interferon regulatory factor 5

Journal of Interferon and Cytokine Research

Volumn 35, Issue 2, 2015, Pages 71-78

  Ryzhakov, Grigory ^a   Eames, Hayley L ^a   Udalova, Irina A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COP9 SIGNALOSOME; INTERFERON REGULATORY FACTOR 5; INTERFERON REGULATORY FACTOR; IRF5 PROTEIN, HUMAN;

DIMERIZATION; GENE; GENE ACTIVATION; HUMAN; INTERFERON REGULATORY FACTOR 5 GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; REVIEW; UBIQUITINATION; ACTIVE TRANSPORT; ANIMAL; CELL NUCLEUS; GENETIC TRANSCRIPTION; METABOLISM; PHYSIOLOGY; PROTEIN PROCESSING; SIGNAL TRANSDUCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL NUCLEUS; HUMANS; INTERFERON REGULATORY FACTORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84922496108     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2014.0023     Document Type: Review

References (64)

1. Balkhi MY, Fitzgerald KA, Pitha PM. 2008. Functional regulation of MyD88-activated interferon regulatory factor 5 by K63-linked polyubiquitination. Mol Cell Biol 28(24):7296-7308.
2. Balkhi MY, Fitzgerald KA, Pitha PM. 2010. IKKalpha negatively regulates IRF-5 function in a MyD88-TRAF6 pathway. Cell Signal 22(1):117-127.
3. Barnes B, Lubyova B, Pitha PM. 2002a. On the role of IRF in host defense. J Interferon Cytokine Res 22(1):59-71.
4. Barnes BJ, Field AE, Pitha-Rowe PM. 2003a. Virus-induced heterodimer formation between IRF-5 and IRF-7 modulates assembly of the IFNA enhanceosome in vivo and transcriptional activity of IFNA genes. J Biol Chem 278(19):16630-16641.
5. Barnes BJ, Kellum MJ, Field AE, Pitha PM. 2002b. Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines thatmediate recruitment of T lymphocytes. Mol Cell Biol 22(16):5721-5740.
6. Barnes BJ, Kellum MJ, Pinder KE, Frisancho JA, Pitha PM. 2003b. Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death. Cancer Res 63(19):6424-6431.
7. Barnes BJ, Moore PA, Pitha PM. 2001. Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes. J Biol Chem 276(26):23382-23390.
8. Bi X, Hameed M, Mirani N, Pimenta EM, Anari J, Barnes BJ. 2011. Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis. Breast Cancer Res 13(6):R111.
9. Chang Foreman HC, Van Scoy S, Cheng TF, Reich NC. 2012. Activation of interferon regulatory factor 5 by site specific phosphorylation. PLoS One 7(3):e33098.
10. Chen W, Lam SS, Srinath H, Jiang Z, Correia JJ, Schiffer CA, Fitzgerald KA, Lin K, Royer WE, Jr. 2008. Insights into interferon regulatory factor activation from the crystal structure of dimeric IRF5. Nat Struct Mol Biol 15(11):1213-1220.
11. Cheng TF, Brzostek S, Ando O, Van Scoy S, Kumar KP, Reich NC. 2006. Differential activation of IFN regulatory factor (IRF)-3 and IRF-5 transcription factors during viral infection. J Immunol 176(12):7462-7470.
12. Cohen H, Azriel A, Cohen T, Meraro D, Hashmueli S, Bech-Otschir D, Kraft R, Dubiel W, Levi BZ. 2000. Interaction between interferon consensus sequence-binding protein and COP9/signalosome subunit CSN2 (Trip15). A possible link between interferon regulatory factor signaling and the COP9/signalosome. J Biol Chem 275(50):39081-39089.
13. Courties G, Heidt T, Sebas M, Iwamoto Y, Jeon D, Truelove J, Tricot B, Wojtkiewicz G, Dutta P, Sager HB, Borodovsky A, Novobrantseva T, Klebanov B, Fitzgerald K, Anderson DG, Libby P, Swirski FK, Weissleder R, Nahrendorf M. 2014. In vivo silencing of the transcription factor IRF5 reprograms the macrophage phenotype and improves infarct healing. J Am Coll Cardiol 63(15):1556-1566.
14. Couzinet A, Tamura K, Chen HM, Nishimura K, Wang Z, Morishita Y, Takeda K, Yagita H, Yanai H, Taniguchi T, Tamura T. 2008. A cell-type-specific requirement for IFN regulatory factor 5 (IRF5) in Fas-induced apoptosis. Proc Natl Acad Sci USA 105(7):2556-2561.
15. Dawidowicz K, Allanore Y, Guedj M, Pierlot C, Bombardieri S, Balsa A, Westhovens R, Barrera P, Alves H, Teixeira VH, Petit-Teixeira E, van de Putte L, van Riel P, Prum B, Bardin T, Meyer O, Cornelis F, Dieude P. 2011. The interferon regulatory factor 5 gene confers susceptibility to rheumatoid arthritis and influences its erosive phenotype. Ann Rheum Dis 70(1):117-121.
16. Del Fresno C, Soulat D, Roth S, Blazek K, Udalova I, Sancho D, Ruland J, Ardavin C. 2013. Interferon-beta production via Dectin-1-Syk-IRF5 signaling in dendritic cells is crucial for immunity to C. albicans. Immunity 38(6):1176-1186.
17. Dideberg V, Kristjansdottir G, Milani L, Libioulle C, Sigurdsson S, Louis E, Wiman AC, Vermeire S, Rutgeerts P, Belaiche J, Franchimont D, Van Gossum A, Bours V, Syvanen AC. 2007. An insertion-deletion polymorphism in the interferon regulatory factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Hum Mol Genet 16(24):3008-3016.
18. Dieguez-Gonzalez R, Calaza M, Perez-Pampin E, de la Serna AR, Fernandez-Gutierrez B, Castaneda S, Largo R, Joven B, Narvaez J, Navarro F, Marenco JL, Vicario JL, Blanco FJ, Fernandez-Lopez JC, Caliz R, Collado-Escobar MD, Carreno L, Lopez-Longo J, Canete JD, Gomez-Reino JJ, Gonzalez A. 2008. Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis. Arthritis Rheum 58(5):1264-1274.
19. Eames HL, Saliba DG, Krausgruber T, Lanfrancotti A, Ryzhakov G, Udalova IA. 2012. KAP1/TRIM28: an inhibitor of IRF5 function in inflammatory macrophages. Immunobiology 217(12):1315-1324.
20. Fang CM, Roy S, Nielsen E, Paul M, Maul R, Paun A, Koentgen F, Raval FM, Szomolanyi-Tsuda E, Pitha PM. 2012. Unique contribution of IRF-5-Ikaros axis to the B-cell IgG2a response. Genes Immun 13(5):421-430.
21. Feng D, Sangster-Guity N, Stone R, Korczeniewska J, Mancl ME, Fitzgerald-Bocarsly P, Barnes BJ. 2010. Differential requirement of histone acetylase and deacetylase activities for IRF5-mediated proinflammatory cytokine expression. J Immunol 185(10):6003-6012.
22. Feng D, Yang L, Bi X, Stone RC, Patel P, Barnes BJ. 2012. Irf5-deficient mice are protected from pristane-induced lupus via increased Th2 cytokines and altered IgG class switching. Eur J Immunol 42(6):1477-1487.
23. Heng TS, Painter MW, Immunological Genome Project C. 2008. The Immunological Genome Project: networks of gene expression in immune cells. Nat Immunol 9(10):1091-1094.
24. Honda K, Taniguchi T. 2006. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6(9):644-658.
25. Hu G, Barnes BJ. 2009. IRF-5 is a mediator of the death receptorinduced apoptotic signaling pathway. J Biol Chem 284(5): 2767-2777.
26. Hu G, Mancl ME, Barnes BJ. 2005. Signaling through IFN regulatory factor-5 sensitizes p53-deficient tumors to DNA damage-induced apoptosis and cell death. Cancer Res 65(16): 7403-7412.
27. Inoue M, Arikawa T, Chen YH, Moriwaki Y, Price M, Brown M, Perfect JR, Shinohara ML. 2014. T cells down-regulate macrophage TNF production by IRAK1-mediated IL-10 expression and control innate hyperinflammation. Proc Natl Acad Sci USA 111(14):5295-5300.
28. Korczeniewska J, Barnes BJ. 2013. The COP9 signalosome interacts with and regulates interferon regulatory factor 5 protein stability. Mol Cell Biol 33(6):1124-1138.
29. Krausgruber T, Blazek K, Smallie T, Alzabin S, Lockstone H, Sahgal N, Hussell T, Feldmann M, Udalova IA. 2011. IRF5 promotes inflammatory macrophage polarization and T(H)1-T(H)17 responses. Nat Immunol 12(3):231-238.
30. Krausgruber T, Saliba D, Ryzhakov G, Lanfrancotti A, Blazek K, Udalova IA. 2010. IRF5 is required for late-phase TNF secretion by human dendritic cells. Blood 115(22):4421-4430.
31. Levy DE, Kessler DS, Pine R, Reich N, Darnell JE, Jr. 1988. Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control. Genes Dev 2(4):383-393.
32. Lien C, Fang CM, Huso D, Livak F, Lu R, Pitha PM. 2010. Critical role of IRF-5 in regulation of B-cell differentiation. Proc Natl Acad Sci USA 107(10):4664-4668.
33. Lin R, Mamane Y, Hiscott J. 1999. Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains. Mol Cell Biol 19(4):2465-2474.
34. Lin R, Yang L, Arguello M, Penafuerte C, Hiscott J. 2005. A CRM1-dependent nuclear export pathway is involved in the regulation of IRF-5 subcellular localization. J Biol Chem 280(4):3088-3095.
35. Mamane Y, Heylbroeck C, Genin P, Algarte M, Servant MJ, LePage C, DeLuca C, Kwon H, Lin R, Hiscott J. 1999. Interferon regulatory factors: the next generation. Gene 237(1):1-14.
36. Massimino M, Consoli ML, Mesuraca M, Stagno F, Tirro E, Stella S, Pennisi MS, Romano C, Buffa P, Bond HM, Morrone G, Sciacca L, Di Raimondo F, Manzella L, Vigneri P. 2014. IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation. Carcinogenesis 35(5):1132-1143.
37. Massimino M, Vigneri P, Fallica M, Fidilio A, Aloisi A, Frasca F, Manzella L. 2012. IRF5 promotes the proliferation of human thyroid cancer cells. Mol Cancer 11:21.
38. Nehyba J, Hrdlickova R, Bose HR. 2009. Dynamic evolution of immune system regulators: the history of the interferon regulatory factor family. Mol Biol Evol 26(11):2539-2550.
39. PandeyAK,YangY, Jiang Z, Fortune SM, Coulombe F, BehrMA, Fitzgerald KA, Sassetti CM, Kelliher MA. 2009. NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathog 5(7):e1000500.
40. Paun A, Bankoti R, Joshi T, Pitha PM, Stager S. 2011. Critical role of IRF-5 in the development of Thelper 1 responses to Leishmania donovani infection. PLoS Pathog 7(1):e1001246.
41. Paun A, Reinert JT, Jiang Z, Medin C, Balkhi MY, Fitzgerald KA, Pitha PM. 2008. Functional characterization of murine interferon regulatory factor 5 (IRF-5) and its role in the innate antiviral response. J Biol Chem 283(21):14295-14308.
42. Purtha WE, Swiecki M, Colonna M, Diamond MS, Bhattacharya D. 2012. Spontaneous mutation of the Dock2 gene in Irf5-/-mice complicates interpretation of type I interferon production and antibody responses. Proc Natl Acad Sci USA 109(15):E898-E904.
43. Reily MM, Pantoja C, Hu X, Chinenov Y, Rogatsky I. 2006. The GRIP1:IRF3 interaction as a target for glucocorticoid receptormediated immunosuppression. EMBO J 25(1):108-117.
44. Richez C, Yasuda K, Bonegio RG, Watkins AA, Aprahamian T, Busto P, Richards RJ, Liu CL, Cheung R, Utz PJ, Marshak-Rothstein A, Rifkin IR. 2010. IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/-mouse models of systemic lupus erythematosus. J Immunol 184(2):796-806.
45. Savitsky D, Tamura T, Yanai H, Taniguchi T. 2010. Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunol Immunother 59(4):489-510.
46. Schoenemeyer A, Barnes BJ, Mancl ME, Latz E, Goutagny N, Pitha PM, Fitzgerald KA, Golenbock DT. 2005. The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling. J Biol Chem 280(17):17005-17012.
47. Schweitzer K, Naumann M. 2010. Control of NF-kappaB activation by the COP9 signalosome. Biochem Soc Trans 38(Pt 1):156-161.
48. Seeger M, Kraft R, Ferrell K, Bech-Otschir D, Dumdey R, Schade R, Gordon C, Naumann M, Dubiel W. 1998. A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits. FASEB J 12(6):469-478.
49. Steinhagen F, McFarland AP, Rodriguez LG, Tewary P, Jarret A, Savan R, Klinman DM. 2013. IRF-5 and NF-kappaB p50 coregulate IFN-beta and IL-6 expression in TLR9-stimulated human plasmacytoid dendritic cells. Eur J Immunol 43(7):1896-1906.
50. Tada Y, Kondo S, Aoki S, Koarada S, Inoue H, Suematsu R, Ohta A, Mak TW, Nagasawa K. 2011. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice. Arthritis Rheum 63(3):738-748.
51. Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, Mizutani T, Kano S, Honda K, Ohba Y, Mak TW, Taniguchi T. 2005. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434(7030):243-249.
52. Tamura T, Yanai H, Savitsky D, Taniguchi T. 2008. The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol 26:535-584.
53. Tanaka N, Kawakami T, Taniguchi T. 1993. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol Cell Biol 13(8):4531-4538.
54. Weiss M, Blazek K, Byrne AJ, Perocheau DP, Udalova IA. 2013. IRF5 is a specific marker of inflammatory macrophages in vivo. Mediators Inflamm 2013:245804.
55. Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S, Wu P, Wiesmann C, Baker R, Boone DL, Ma A, Koonin EV, Dixit VM. 2004. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430(7000):694-699.
56. Xu D, Meyer F, Ehlers E, Blasnitz L, Zhang L. 2011. Interferon regulatory factor 4 (IRF-4) targets IRF-5 to regulate Epstein-Barr virus transformation. J Biol Chem 286(20):18261-18267.
57. Xu Y, Lee PY, Li Y, Liu C, Zhuang H, Han S, Nacionales DC, Weinstein J, Mathews CE, Moldawer LL, Li SW, Satoh M, Yang LJ, Reeves WH. 2012. Pleiotropic IFN-dependent and-independent effects of IRF5 on the pathogenesis of experimental lupus. J Immunol 188(8):4113-4121.
58. Yamashita M, Toyota M, Suzuki H, Nojima M, Yamamoto E, Kamimae S, Watanabe Y, Kai M, Akashi H, Maruyama R, Sasaki Y, Yamano H, Sugai T, Shinomura Y, Imai K, Tokino T, Itoh F. 2010. DNA methylation of interferon regulatory factors in gastric cancer and noncancerous gastric mucosae. Cancer Sci 101(7):1708-1716.
59. Yanai H, Chen HM, Inuzuka T, Kondo S, Mak TW, Takaoka A, Honda K, Taniguchi T. 2007. Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression. Proc Natl Acad Sci USA 104(9):3402-3407.
60. Yang H, Lin CH, Ma G, Orr M, Baffi MO, Wathelet MG. 2002. Transcriptional activity of interferon regulatory factor (IRF)-3 depends on multiple protein-protein interactions. Eur J Biochem 269(24):6142-6151.
61. Yang L, Feng D, Bi X, Stone RC, Barnes BJ. 2012. Monocytes from Irf5-/-mice have an intrinsic defect in their response to pristane-induced lupus. J Immunol 189(7):3741-3750.
62. Yasuda K, Nundel K, Watkins AA, Dhawan T, Bonegio RG, Ubellacker JM, Marshak-Rothstein A, Rifkin IR. 2013. Phenotype and function of B cells and dendritic cells from interferon regulatory factor 5-deficient mice with and without a mutation in DOCK2. Int Immunol 25(5):295-306.
63. Yeon SI, Youn JH, Lim MH, Lee HJ, Kim YM, Choi JE, Lee JM, Shin JS. 2008. Development of monoclonal antibodies against human IRF-5 and their use in identifying the binding of IRF-5 to nuclear import proteins karyopherin-alpha1 and-beta1. Yonsei Med J 49(6):1023-1031.
64. Yoshida A, Yoneda-Kato N, Kato JY. 2013. CSN5 specifically interacts with CDK2 and controls senescence in a cytoplasmic cyclin E-mediated manner. Sci Rep 3:1054.